Thereson has been founded in June 2011 with the mission of developing medical technology and devices based on the method of the Pulsating Electro-Magnetic Fields (PEMF), for treating serious pathologies like the Diabetic Foot (DF) ulcers.
The TMR technology of Thereson has been conceived to be used in hospital, for the first or acute applications, but more often at home for the longer term protocols typical of DF treatment.
Thereson is committed to provide quality to its Customers and stakeholders in all its activities and outputs: physical products, services, communications, scientific work and relationships with Clients, partners and regulatory authorities.
Thereson has been founded in June 2011 with the mission of developing medical technology and devices based on the method of the Pulsating Electro-Magnetic Fields (PEMF), for treating serious pathologies like the Diabetic Foot (DF) ulcers.
The main technology of Thereson is an advanced form of magnetic therapy called Therapeutic Magnetic Resonance (TMR).
TMR has proven to be effective in the treatment of ulcers and chronic wounds. 
The TMR technology of Thereson has been conceived to be used in hospital, for the first or acute applications, but more often at home for the longer term protocols typical of DF treatment. 
Thereson is committed to provide quality to its Customers and stakeholders in all its activities and outputs: physical products, services, communications, scientific work and relationships with Clients, partners and regulatory authorities.